carotenoids Not classified
No linked studies yet.
$70.00 $2.33 per serving
Product analysis
Memoractiv may support stress management and some aspects of memory or attention, with the clearest connection coming from its ashwagandha extract. Effects depend on the preparation and person, while its acetyl L-carnitine and bacopa components offer weak value for the cost.
AI assessment of the formula, label and price. How scoring works
Nutrient Quality37
Ingredient quality remains uncertain despite several named preparations. Bacopa lacks preparation details, and the marigold-derived ingredient has unresolved quantity and composition details.
Ingredient Transparency83
Ingredient amounts and most forms are disclosed, helping identify the main components. Bacopa preparation details are missing, while the marigold-derived ingredient has conflicting quantities and an unclear composition.
Value For Money32
The acetyl L-carnitine component is expensive for the amount supplied, and bacopa also compares poorly on serving cost. Value for the remaining ingredients is unresolved.
Customer Satisfaction75
Customer feedback is very positive across hundreds of ratings. That gives useful context for satisfaction, without confirming memory or focus improvements.
Product Focus61
The clearest links are to stress management and selected memory or attention tasks, with effects depending on the extract and user. The many possible uses extend beyond that core purpose, and the caffeine amount is too uncertain to establish an alertness contribution.
- Format
Capsule - Container
- 60 Capsule(s)
- Per serving
- $2.33
- Customer rating
- 4.6 · 510 ratings
Goals
Impact
High effect
The carotenoid ingredient relates to macular pigment, but its preparation is not matched to the studied material in the supplied findings. Ginkgo has inconsistent evidence in a glaucoma population, which does not establish support for routine visual performance. The amounts present cannot resolve those differences in preparation and population.
How this product is rated for Eye Health
Ingredient fit66
Vision-related ingredients form only part of a formula that also addresses other goals. The included amounts partly meet the saved references; an unresolved amount cannot establish a dose contribution.
Goal fit
Vision-related ingredients form only part of a formula that also addresses other goals.
Dose adequacy
The included amounts partly meet the saved references; an unresolved amount cannot establish a dose contribution.
Pathways60
The strongest represented mechanism is ocular microcirculation. This describes ingredient roles rather than demonstrated visual improvement.
Depth
The strongest represented mechanism is ocular microcirculation. This describes ingredient roles rather than demonstrated visual improvement.
Breadth
Coverage is concentrated in one mechanism rather than spread across several aspects of vision.
Evidence50
The lutein-related ingredient supplies the strongest included evidence contribution; preparation and population limitations still apply.
Evidence strength
The lutein-related ingredient supplies the strongest included evidence contribution; preparation and population limitations still apply.
Studied preparation
The carotenoid preparation does not match the studied material; other included preparations match the saved findings.
Formulation logic100
All included contributors meet the saved minimum amount threshold, which is not a proven minimum effective dose.
Partner coverage
The included contributors can act independently or have their required partner; this does not establish combination synergy.
Conflicts
No matching ingredient conflict was identified in the supplied findings.
Effective doses
All included contributors meet the saved minimum amount threshold, which is not a proven minimum effective dose.
Impact
High effect
Acetyl L-Carnitine · 250 mg
Ashwagandha has small, preparation-specific attention and processing-speed findings, including KSM-66, with uncertain transfer to routine acute focus. Acetyl L-carnitine and ginkgo provide cognitive connections but do not establish healthy acute attention benefits from the supplied studies. Bacopa is present at a small amount without identification of the acute-study extract. The caffeine declaration remains unresolved, so no caffeine exposure can be established.
How this product is rated for Mental Focus
Ingredient fit61
Acetyl L-Carnitine contributes to the relevant ingredient mix. Amount limitations reduce the contribution.
Goal fit
Acetyl L-Carnitine contributes to focus, while other ingredients serve broader purposes.
Dose adequacy
Small or unresolved amounts reduce how directly the serving compares with the reviewed exposures.
Pathways69
The recorded connection centers on cerebral energy supply. Another process also contributes.
Depth
The strongest recorded connection is to cerebral energy supply, without establishing a measured attention improvement.
Breadth
Two processes carry the recorded contributions; other aspects of focus have less coverage.
Evidence83
Acetyl L-Carnitine leads the saved findings, but the supplied human evidence remains limited in task scope, preparation or population.
Evidence strength
Acetyl L-Carnitine leads the saved evidence findings, with limited or task-specific support for routine acute focus.
Studied preparation
The saved findings recognize the contributing preparations, without establishing the same context or clinical outcome.
Formulation logic100
The retained ingredients have no missing configured partner or identified conflict.
Partner coverage
The retained ingredients work alone or have their configured partner in the supplied findings.
Conflicts
No configured ingredient conflict was identified in the supplied calculation.
Effective doses
The retained contributing ingredients clear the saved amount threshold, which does not prove an effective focus dose.
Impact
High effect
Ashwagandha · 300 mgBacopa · 100 mg
Ashwagandha’s cognitive-task findings depend on an identified studied extract and concern limited populations. Bacopa’s memory-learning findings also require an appropriate extract and repeated use; a small serving cannot be assumed equivalent to a multiweek trial regimen. Caffeine can support short-term alertness, while ginkgo and acetyl L-carnitine do not establish prevention of cognitive decline or broad healthy-adult cognitive benefit.
How this product is rated for Brain Health
Ingredient fit65
Ingredients serving other purposes broaden the formula beyond its brain-health contribution.
Goal fit
Ingredients serving other purposes broaden the formula beyond its brain-health contribution.
Dose adequacy
Some declared amounts or unresolved exposures provide only partial support against the supplied comparison amounts.
Pathways68
The strongest represented mechanism is cerebral energy metabolism, with the relevant ingredient limitations still applying.
Depth
The strongest represented mechanism is cerebral energy metabolism, with the relevant ingredient limitations still applying.
Breadth
The ingredients represent two mechanisms, although this does not prove broader cognitive improvement.
Evidence93
Ashwagandha leads the evidence finding, within the supplied population and outcome limitations.
Evidence strength
Ashwagandha leads the evidence finding, within the supplied population and outcome limitations.
Studied preparation
Preparation matching remains incomplete for Bacopa, so equivalent trial exposure cannot be assumed.
Formulation logic100
The relevant ingredients work independently or have the required partner. No configured conflict is identified in the supplied ingredient findings.
Partner coverage
The relevant ingredients work independently or have the required partner.
Conflicts
No configured conflict is identified in the supplied ingredient findings.
Effective doses
The included ingredients meet the minimum amount comparison; that threshold does not establish a proven cognitive dose.
Impact
Moderate effect
Ashwagandha · 300 mgAcetyl L-Carnitine · 250 mgBacopa · 100 mg
Ginkgo at 240 mg has tentative relevance to attention speed, although Virtiva is not interchangeable with the preparation in the supplied acute evidence. KSM-66 ashwagandha at 300 mg offers preparation-specific relevance to selected memory and attention tasks, with limited applicability across people.
Acetyl L-carnitine relates to brain energy processes, but its cited clinical evidence does not establish routine focus benefits in healthy adults. Bacopa is present at only 100 mg, and the caffeine amount is undisclosed, so a meaningful alertness contribution cannot be assessed.
How this product is rated for Cognitive Support
Ingredient fit58
The formula is relatively focused on cognitive ingredients, but several amounts or preparations limit their contribution. Ginkgo reaches its saved comparison level, while ashwagandha and acetyl L-carnitine provide partial exposures. Caffeine has no disclosed amount, and bacopa is below the level counted.
Goal fit
The formula is relatively focused on cognitive ingredients, but several amounts or preparations limit their contribution.
Dose adequacy
Ginkgo reaches its saved comparison level, while ashwagandha and acetyl L-carnitine provide partial exposures. Caffeine has no disclosed amount, and bacopa is below the level counted.
Pathways40
Blood-flow-related support is strongest, with smaller contributions related to brain energy and stress regulation. Only the blood-flow-related route reaches the saved coverage level; energy and stress contributions are smaller.
Depth
Blood-flow-related support is strongest, with smaller contributions related to brain energy and stress regulation.
Breadth
Only the blood-flow-related route reaches the saved coverage level; energy and stress contributions are smaller.
Evidence81
Ashwagandha provides the strongest saved evidence contribution at a counted amount, with selected memory and attention outcomes. The saved preparation assessment is partly supported; ginkgo is not identified as the specific studied extract.
Evidence strength
Ashwagandha provides the strongest saved evidence contribution at a counted amount, with selected memory and attention outcomes.
Studied preparation
The saved preparation assessment is partly supported; ginkgo is not identified as the specific studied extract.
Formulation logic94
The counted ingredients can contribute independently or have their required partner. Three of the four counted ingredients meet the saved minimum exposure comparison; caffeine does not because its amount is unknown.
Partner coverage
The counted ingredients can contribute independently or have their required partner.
Conflicts
No configured ingredient conflict was identified in the saved assessment.
Effective doses
Three of the four counted ingredients meet the saved minimum exposure comparison; caffeine does not because its amount is unknown.
Impact
Moderate effect
Acetyl L-Carnitine · 250 mgAcetyl L-Carnitine · 250 mg
Bacopa has preparation-specific memory and information-processing evidence after repeated use, although its 100 mg preparation was not matched to the reviewed trials. Ginkgo, acetyl L-carnitine and ashwagandha have limited or context-dependent relevance to everyday productivity.
Caffeine remains unresolved in the supplied facts; the 116 mg botanical amount cannot be used as caffeine mass or assumed to improve alertness.
How this product is rated for Productivity Boost
Ingredient fit65
4 assessed ingredients relate to productivity, alongside 1 other active ingredients aimed at broader needs. The assessed amounts provide a partial match to the reviewed exposure ranges.
Goal fit
4 assessed ingredients relate to productivity, alongside 1 other active ingredients aimed at broader needs.
Dose adequacy
The assessed amounts provide a partial match to the reviewed exposure ranges.
Pathways14
Synaptic plasticity and neuroprotection is the main area of support identified in the saved assessment. Support remains narrow, with no assessed mechanism reaching the saved coverage threshold.
Depth
Synaptic plasticity and neuroprotection is the main area of support identified in the saved assessment.
Breadth
Support remains narrow, with no assessed mechanism reaching the saved coverage threshold.
Evidence63
Acetyl L-Carnitine provides the strongest evidence contribution at an assessed meaningful amount; the clinical context still matters. Most assessed preparations match the saved evidence review, but Bacopa was not matched to a reviewed trial preparation.
Evidence strength
Acetyl L-Carnitine provides the strongest evidence contribution at an assessed meaningful amount; the clinical context still matters.
Studied preparation
Most assessed preparations match the saved evidence review, but Bacopa was not matched to a reviewed trial preparation.
Formulation logic100
The assessed ingredients can contribute alone or have their required partner present. No ingredient conflicts were identified in the saved assessment. 4 of 4 assessed ingredients meet the saved amount threshold.
Partner coverage
The assessed ingredients can contribute alone or have their required partner present.
Conflicts
No ingredient conflicts were identified in the saved assessment.
Effective doses
4 of 4 assessed ingredients meet the saved amount threshold.
Impact
Moderate effect
Acetyl L-Carnitine · 250 mg
Ashwagandha at 300 mg relates to coping with stress-related fatigue, and acetyl L-carnitine at 250 mg relates to cellular energy processes. The supplied human findings depend on specific preparations and selected populations, so a reliable everyday energy boost remains uncertain.
How this product is rated for Energy
Ingredient fit43
The formula serves several needs, so only part of it is focused on energy support. Small or unresolved relevant amounts limit the contribution.
Goal fit
The formula serves several needs, so only part of it is focused on energy support.
Dose adequacy
Small or unresolved relevant amounts limit the contribution.
Pathways40
Stress-fatigue resistance is the strongest area in the saved findings, with a smaller contribution related to cellular energy. The saved findings show meaningful coverage of one aspect of energy support, with less coverage elsewhere.
Depth
Stress-fatigue resistance is the strongest area in the saved findings, with a smaller contribution related to cellular energy.
Breadth
The saved findings show meaningful coverage of one aspect of energy support, with less coverage elsewhere.
Evidence95
Acetyl L-Carnitine provides the strongest relevant evidence at the assessed amount, with benefits dependent on nutritional status or clinical context. The qualifying ingredients match preparations represented in the supplied evidence.
Evidence strength
Acetyl L-Carnitine provides the strongest relevant evidence at the assessed amount, with benefits dependent on nutritional status or clinical context.
Studied preparation
The qualifying ingredients match preparations represented in the supplied evidence.
Formulation logic100
The assessed ingredients can contribute on their own or have their required partner present. No ingredient conflicts were identified in the saved assessment. All assessed ingredients met the saved minimum amount criterion.
Partner coverage
The assessed ingredients can contribute on their own or have their required partner present.
Conflicts
No ingredient conflicts were identified in the saved assessment.
Effective doses
All assessed ingredients met the saved minimum amount criterion.
Ingredients
| Ingredient | Amount per serving | Score |
|---|---|---|
KSM-66 (Ashwagandha root extract) | 300 mg | |
Acetyl-L-Carnitine (Acetyl-L-Carnitine Chloride) | 250 mg | |
Virtiva (Ginkgo Phytosome) | 240 mg | |
PURENERGY (Caffeine Pterostilbene Complex) | 116 mg | |
Bacopa leaf extract | 100 mg | |
Lutemax 2020 (Lutein) | 10 mg | |
Lutemax 2020 (Zeaxanthin Isomers) | 2 mg |
Ashwagandha (Ashwagandha root extract) · 300 mg OverallScore65
Acetyl L-Carnitine (Acetyl-L-Carnitine Chloride) · 250 mg OverallScore63
A serving provides 250 mg of acetyl L-carnitine. The whole-product price corresponds to about $4.67 per 500 mg of acetyl L-carnitine.
How this ingredient is rated
Active Ingredient Quality & Bioavailability79
Acetyl L-carnitine is identified, though the saved facts do not specify its salt or report a purity or manufacturing claim.
ALCAR vs. Standard Carnitine Form
Acetyl L-carnitine is identified; no other carnitine is recorded in the active ingredient information.
Advanced Sourcing and Salt Specificity
The saved facts do not identify a specific salt or report a purity or manufacturing claim.
Dose, Safety & Label Transparency79
The exact amount is stated as 250 mg per serving.
Clinical Dosage Efficacy
A serving provides 250 mg of acetyl L-carnitine.
Label Transparency and Proprietary Blends
The ingredient's individual amount is disclosed as 250 mg per serving.
Value0
The whole-product price corresponds to about $4.67 per 500 mg of acetyl L-carnitine.
Price per 500mg Acetyl L-Carnitine
Based on the whole-product price and stated amount, 500 mg corresponds to about $4.67.
Ginkgo (Ginkgo Phytosome) · 240 mg OverallScore50
A serving lists 240 mg of ginkgo phytosome. That is the amount of the preparation, and the saved facts do not specify its separate ginkgo extract amount.
How this ingredient is rated
Composition and Label Disclosure0
The phytosome preparation is named, but marker percentages and a ginkgolic acid limit are unavailable in the saved facts.
Marker and Preparation Disclosure
The preparation is recorded as ginkgo phytosome; the saved facts do not include flavone or terpene percentages.
Declared Ginkgolic Acid Limit
The saved facts do not contain a qualifying ginkgolic acid limit; that does not establish its concentration.
Composition and Label Disclosure100
The named preparation and its amount are disclosed: 240 mg of ginkgo phytosome per serving.
Individual Preparation Amount Disclosure
A serving lists 240 mg of ginkgo phytosome.
Commercial Price and Usability
The whole-product serving costs about $2.33; no separate value assessment is provided.
Alternative products
Report alternatives
Sources
Published studies used for the product analysis and the top-ranked studies for each ingredient and goal.
- Acetyl-L-carnitine treatment in minimal hepatic encephalopathy.
- Long-term acetyl-L-carnitine treatment in Alzheimer's disease.
- Pharmaco-electroencephalographic and clinical effects of the cholinergic substance--acetyl-L-carnitine--in patients with organic brain syndrome.
- Acetyl-L-carnitine improves cognitive functions in severe hepatic encephalopathy: a randomized and controlled clinical trial.
- Acetyl-L-carnitine in the treatment of mildly demented elderly patients.
- Acute and Repeated Ashwagandha Supplementation Improves Markers of Cognitive Function and Mood.
- Effect of ashwagandha (Withania somnifera) extract with Sominone (Somin-On™) to improve memory in adults with mild cognitive impairment: A randomized, double-blind, placebo-controlled study.
- Efficacy of Withania somnifera supplementation on adult's cognition and mood.
- A clinical assessment of the therapeutic effects of Ashwagandha root extract on cognitive performance, sleep, and fatigue in children aged 6-12 years.
- Efficacy and Safety of Ashwagandha Root Extract on Cognitive Functions in Healthy, Stressed Adults: A Randomized, Double-Blind, Placebo-Controlled Study.
- Comparative effects of Bacopa monnieri and Ginkgo biloba on cognitive functions: A systematic review and network meta-analysis.
- Meta-analysis of randomized controlled trials on cognitive effects of Bacopa monnieri extract.
- Comparative efficacy of Medhya Rasayana,Bacopa monnieri, and Centella asiatica in enhancing memory and IQ of 8-10 year-old healthy boys: A prakriti-based double-blind, randomized controlled trial.
- Plant-derived nootropics and human cognition: A systematic review.
- The effect of plant active substances on cognitive function in healthy older adults: a systematic review and network meta-analysis of randomized controlled trials.
- Efficacy and adverse effects of ginkgo biloba for cognitive impairment and dementia: a systematic review and meta-analysis.
- Efficacy of Ginkgo biloba extract EGb 761® in dementia with behavioural and psychological symptoms: A systematic review.
- Ginkgo biloba extract EGb 761 is safe and effective in the treatment of mild dementia - a meta-analysis of patient subgroups in randomised controlled trials.
- Ginkgo biloba extract EGb 761® improves cognition and overall condition after ischemic stroke: Results from a pilot randomized trial.
- Ginkgo biloba extract EGb 761® in dementia with neuropsychiatric features: a randomised, placebo-controlled trial to confirm the efficacy and safety of a daily dose of 240 mg.